DATATRAK International, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2018
July 31, 2018 at 04:08 pm EDT
Share
DATATRAK International, Inc. reported unaudited consolidated earnings results for the second quarter ended June 30, 2018. For the quarter, the company's revenue was $1,931,340 compared to $1,906,236 a year ago. Income from operations was $159,390 compared to $152,263 a year ago. Net income before income taxes was $160,092 compared to $103,801 a year ago. Net income was $160,092 compared to $103,801 a year ago. Net income per share, diluted was $0.07 compared to $0.06 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
